Literature DB >> 21180225

Tamoxifen for breast cancer.

A Karn1, A K Jha, S Shrestha, B Acharya, S Poudel, R B Bhandari.   

Abstract

Breast cancer is one of the common cancers. Hormonal therapy along with surgery, chemotherapy, radiotherapy and targeted therapy are vital modalities for the management of breast cancer. Tamoxifen has been the most widely used hormonal therapy for more than two decades. In this article we review the benefits, dose, duration and timing of Tamoxifen therapy in patients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21180225

Source DB:  PubMed          Journal:  JNMA J Nepal Med Assoc        ISSN: 0028-2715            Impact factor:   0.406


  8 in total

Review 1.  Tamoxifen use for the management of mania: a review of current preclinical evidence.

Authors:  Fernanda Armani; Monica Levy Andersen; José Carlos Fernandes Galduróz
Journal:  Psychopharmacology (Berl)       Date:  2014-01-18       Impact factor: 4.530

2.  Tamoxifen induces apoptosis of mouse microglia cell line BV-2 cells via both mitochondrial and death receptor pathways.

Authors:  Zhengwei Li; Jincao Chen; Ting Lei; Huaqiu Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20

3.  β-Boswellic Acid Suppresses Breast Precancerous Lesions via GLUT1 Targeting-Mediated Glycolysis Inhibition and AMPK Pathway Activation.

Authors:  Fengjie Bie; Guijuan Zhang; Xianxin Yan; Xinyi Ma; Sha Zhan; Yebei Qiu; Jingyu Cao; Yi Ma; Min Ma
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

4.  Breast Cancer in Nepal: Current status and future directions.

Authors:  Mohan Giri; Mamata Giri; Rabin Jung Thapa; Bibhuti Upreti; Bijay Pariyar
Journal:  Biomed Rep       Date:  2018-02-05

5.  CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.

Authors:  Paul L Prather; FeAna FrancisDevaraj; Centdrika R Dates; Aleksandra K Greer; Stacie M Bratton; Benjamin M Ford; Lirit N Franks; Anna Radominska-Pandya
Journal:  Biochem Biophys Res Commun       Date:  2013-10-19       Impact factor: 3.575

6.  Repurposing of Tamoxifen Against the Oral Bacteria.

Authors:  Ali Abdul Hussein S Al-Janabi
Journal:  Turk J Pharm Sci       Date:  2021-02-25

7.  Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samples.

Authors:  Anna Dvorkin-Gheva; John A Hassell
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

Review 8.  Interactions Between Natural Products and Tamoxifen in Breast Cancer: A Comprehensive Literature Review.

Authors:  Christine Yen; Fan Zhao; Zhichao Yu; Xiaoshu Zhu; Chun Guang Li
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.